April 28, 2006, Newsletter Issue #13: What reforms are being suggested to prevent the FDA from approving dangerous drugs?
Tip of the Week
In the wake of the Vioxx and Bextra recalls, a coalition of health and consumer groups is calling for reform in the process used by the FDA to test and approve new drugs. These groups include the Center for Science in the Public Interest, the National Women's Health Network, the Center for Medical Consumers, the U.S. Cochrane Center Consumer Coalition, and several other health-advocacy groups. They charge that the FDA has become too reliant on scientists connected with industry that it routinely grants waivers for conflicts of interest. The groups are also calling for greater transparency and for greater opportunities for public participation in the federal advisory committee process.
About LifeTips
Now one of the top on-line publishers in the world, LifeTips offers tips to millions of monthly visitors. Our mission mission is to make your life smarter, better, faster and wiser. Expert writers earn dough for what they know. And exclusive sponsors in each niche topic help us make-it-all happen.
